Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2
Crossref DOI link: https://doi.org/10.1007/978-3-319-91442-8_5
Published Online: 2018-08-02
Published Print: 2018
Update policy: https://doi.org/10.1007/springer_crossmark_policy
GrĂ¼llich, Carsten
License valid from 2018-01-01